How to buy Medtronic (MDT) stocks

Medtronic is a medical devices business based in the US. Medtronic shares (MDT) are listed on the NYSE and all prices are listed in US Dollars.

Its last market close was $80.03 – a decrease of 3.26% over the previous week. Medtronic employs 95,000 staff and has a trailing 12-month revenue of around $32.6 billion.

Our top picks for where to buy Medtronic stock

Buy Medtronic stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Medtronic stock price (NYSE: MDT)

Use our graph to track the performance of MDT stocks over time.

Medtronic stocks at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$80.03
52-week range	$75.37 - $92.68
50-day moving average more info button	$87.45
200-day moving average more info button	$84.44
Wall St. target price	$96.11
PE ratio more info button	24.474
Dividend yield more info button	$0 (3.2%)
Earnings per share (TTM) more info button	$3.27

Is it a good time to buy Medtronic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Medtronic price performance over time

Historical closes compared with the close of $81.37 from 2024-12-17

1 week (2024-12-12)	-1.64%
1 month (2024-11-19)	-4.27%
3 months (2024-09-19)	-9.05%
6 months (2024-06-18)	2.03%

1 year (2023-12-19)	-0.85%
2 years (2022-12-19)	12.83%
3 years (2021-12-17)	91.5133
5 years (2019-12-19)	98.8528

Is Medtronic stock undervalued or overvalued?

Valuing Medtronic stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medtronic's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Medtronic's P/E ratio

Medtronic's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Medtronic shares trade at around 24x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stock or simply that they're under-valued.

Medtronic's PEG ratio

Medtronic's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4856. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medtronic's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

Medtronic's EBITDA

Medtronic's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9 billion.

The EBITDA is a measure of a Medtronic's overall financial performance and is widely used to measure a its profitability.

Medtronic financials

Revenue TTM	$32.6 billion
Operating margin TTM	17.51%
Gross profit TTM	$21.7 billion
Return on assets TTM	4.42%
Return on equity TTM	7.95%
Profit margin	12.06%
Book value	$38.29
Market Capitalization more info button	$102.6 billion

TTM: trailing 12 months

Medtronic stock dividends

Dividend payout ratio: 53.14% of net profits

Recently Medtronic has paid out, on average, around 100% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medtronic shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Medtronic's case, that would currently equate to about $0 per share.

Medtronic's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

Medtronic's most recent dividend payout was on 9 January 2025. The latest dividend was paid out to all shareholders who bought their stocks by 26 September 2024 (the "ex-dividend date").

Have Medtronic's stocks ever split?

Medtronic's stocks were split on a 2:1 basis on 26 September 1999 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Medtronic stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for Medtronic stocks, which in turn could have impacted Medtronic's stock price.

Medtronic stock price volatility

Over the last 12 months, Medtronic's stocks have ranged in value from as little as $75.3656 up to $92.68. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while Medtronic's is 0.853. This would suggest that Medtronic's stocks are less volatile than average (for this exchange).

Medtronic overview

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Medtronic is owned by insiders or institutions?
Currently 0.258% of Medtronic stocks are held by insiders and 85.42% by institutions. How many people work for Medtronic?
Latest data suggests 95,000 work at Medtronic. When does the fiscal year end for Medtronic?
Medtronic's fiscal year ends in April. Where is Medtronic based?
Medtronic's address is: Building Two, Galway, Ireland What is Medtronic's ISIN number?
Medtronic's international securities identification number is: IE00BTN1Y115 What is Medtronic's CUSIP number?
Medtronic's Committee on Uniform Securities Identification Procedures number is: 585055106

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.